nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefuroxime—Disability—Thalidomide—leprosy	0.13	0.13	CcSEcCtD
Cefuroxime—Creatinine low—Thalidomide—leprosy	0.0852	0.0852	CcSEcCtD
Cefuroxime—Blood creatinine decreased—Thalidomide—leprosy	0.078	0.078	CcSEcCtD
Cefuroxime—Liver disorder—Thalidomide—leprosy	0.024	0.024	CcSEcCtD
Cefuroxime—Cholestasis—Thalidomide—leprosy	0.0215	0.0215	CcSEcCtD
Cefuroxime—Musculoskeletal stiffness—Thalidomide—leprosy	0.0182	0.0182	CcSEcCtD
Cefuroxime—Creatinine increased—Thalidomide—leprosy	0.0172	0.0172	CcSEcCtD
Cefuroxime—Sinusitis—Dapsone—leprosy	0.0167	0.0167	CcSEcCtD
Cefuroxime—Phosphatase alkaline increased—Thalidomide—leprosy	0.0163	0.0163	CcSEcCtD
Cefuroxime—Colitis—Thalidomide—leprosy	0.0157	0.0157	CcSEcCtD
Cefuroxime—Candida infection—Thalidomide—leprosy	0.0156	0.0156	CcSEcCtD
Cefuroxime—Blood urea increased—Thalidomide—leprosy	0.0154	0.0154	CcSEcCtD
Cefuroxime—Aplastic anaemia—Thalidomide—leprosy	0.0153	0.0153	CcSEcCtD
Cefuroxime—Hyperkinesia—Thalidomide—leprosy	0.0142	0.0142	CcSEcCtD
Cefuroxime—Erythema—Dapsone—leprosy	0.0139	0.0139	CcSEcCtD
Cefuroxime—Thrombophlebitis—Thalidomide—leprosy	0.0137	0.0137	CcSEcCtD
Cefuroxime—Blood alkaline phosphatase increased—Thalidomide—leprosy	0.0136	0.0136	CcSEcCtD
Cefuroxime—Cough—Dapsone—leprosy	0.0122	0.0122	CcSEcCtD
Cefuroxime—Tachycardia—Dapsone—leprosy	0.0111	0.0111	CcSEcCtD
Cefuroxime—Blood creatinine increased—Thalidomide—leprosy	0.0111	0.0111	CcSEcCtD
Cefuroxime—Toxic epidermal necrolysis—Thalidomide—leprosy	0.0107	0.0107	CcSEcCtD
Cefuroxime—Cramp muscle—Thalidomide—leprosy	0.0107	0.0107	CcSEcCtD
Cefuroxime—Eosinophilia—Thalidomide—leprosy	0.0101	0.0101	CcSEcCtD
Cefuroxime—Bronchitis—Thalidomide—leprosy	0.00986	0.00986	CcSEcCtD
Cefuroxime—Pancytopenia—Thalidomide—leprosy	0.00973	0.00973	CcSEcCtD
Cefuroxime—Neutropenia—Thalidomide—leprosy	0.00958	0.00958	CcSEcCtD
Cefuroxime—Upper respiratory tract infection—Thalidomide—leprosy	0.00952	0.00952	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Dapsone—leprosy	0.00931	0.00931	CcSEcCtD
Cefuroxime—Drowsiness—Thalidomide—leprosy	0.00914	0.00914	CcSEcCtD
Cefuroxime—Infestation NOS—Thalidomide—leprosy	0.00914	0.00914	CcSEcCtD
Cefuroxime—Infestation—Thalidomide—leprosy	0.00914	0.00914	CcSEcCtD
Cefuroxime—Stevens-Johnson syndrome—Thalidomide—leprosy	0.00906	0.00906	CcSEcCtD
Cefuroxime—Abdominal pain—Dapsone—leprosy	0.009	0.009	CcSEcCtD
Cefuroxime—Body temperature increased—Dapsone—leprosy	0.009	0.009	CcSEcCtD
Cefuroxime—Renal failure—Thalidomide—leprosy	0.00898	0.00898	CcSEcCtD
Cefuroxime—Stomatitis—Thalidomide—leprosy	0.00891	0.00891	CcSEcCtD
Cefuroxime—Sweating—Thalidomide—leprosy	0.00876	0.00876	CcSEcCtD
Cefuroxime—Sinusitis—Thalidomide—leprosy	0.00857	0.00857	CcSEcCtD
Cefuroxime—Agranulocytosis—Thalidomide—leprosy	0.00853	0.00853	CcSEcCtD
Cefuroxime—Hepatitis—Thalidomide—leprosy	0.0082	0.0082	CcSEcCtD
Cefuroxime—Urinary tract disorder—Thalidomide—leprosy	0.0081	0.0081	CcSEcCtD
Cefuroxime—Urethral disorder—Thalidomide—leprosy	0.00804	0.00804	CcSEcCtD
Cefuroxime—Erythema multiforme—Thalidomide—leprosy	0.00776	0.00776	CcSEcCtD
Cefuroxime—Angiopathy—Thalidomide—leprosy	0.00744	0.00744	CcSEcCtD
Cefuroxime—Immune system disorder—Thalidomide—leprosy	0.00741	0.00741	CcSEcCtD
Cefuroxime—Chills—Thalidomide—leprosy	0.00736	0.00736	CcSEcCtD
Cefuroxime—Vomiting—Dapsone—leprosy	0.00724	0.00724	CcSEcCtD
Cefuroxime—Headache—Dapsone—leprosy	0.00713	0.00713	CcSEcCtD
Cefuroxime—Flatulence—Thalidomide—leprosy	0.00704	0.00704	CcSEcCtD
Cefuroxime—Muscle spasms—Thalidomide—leprosy	0.00687	0.00687	CcSEcCtD
Cefuroxime—Nausea—Dapsone—leprosy	0.00676	0.00676	CcSEcCtD
Cefuroxime—Agitation—Thalidomide—leprosy	0.00656	0.00656	CcSEcCtD
Cefuroxime—Angioedema—Thalidomide—leprosy	0.00652	0.00652	CcSEcCtD
Cefuroxime—Leukopenia—Thalidomide—leprosy	0.00639	0.00639	CcSEcCtD
Cefuroxime—Palpitations—Thalidomide—leprosy	0.00631	0.00631	CcSEcCtD
Cefuroxime—Cough—Thalidomide—leprosy	0.00623	0.00623	CcSEcCtD
Cefuroxime—Convulsion—Thalidomide—leprosy	0.00619	0.00619	CcSEcCtD
Cefuroxime—Arthralgia—Thalidomide—leprosy	0.00608	0.00608	CcSEcCtD
Cefuroxime—Chest pain—Thalidomide—leprosy	0.00608	0.00608	CcSEcCtD
Cefuroxime—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.00604	0.00604	CcSEcCtD
Cefuroxime—Thrombocytopenia—Thalidomide—leprosy	0.00571	0.00571	CcSEcCtD
Cefuroxime—Tachycardia—Thalidomide—leprosy	0.00569	0.00569	CcSEcCtD
Cefuroxime—Skin disorder—Thalidomide—leprosy	0.00566	0.00566	CcSEcCtD
Cefuroxime—Hyperhidrosis—Thalidomide—leprosy	0.00563	0.00563	CcSEcCtD
Cefuroxime—Anorexia—Thalidomide—leprosy	0.00556	0.00556	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Thalidomide—leprosy	0.00531	0.00531	CcSEcCtD
Cefuroxime—Dyspnoea—Thalidomide—leprosy	0.0052	0.0052	CcSEcCtD
Cefuroxime—Somnolence—Thalidomide—leprosy	0.00518	0.00518	CcSEcCtD
Cefuroxime—Dyspepsia—Thalidomide—leprosy	0.00513	0.00513	CcSEcCtD
Cefuroxime—Decreased appetite—Thalidomide—leprosy	0.00507	0.00507	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Thalidomide—leprosy	0.00503	0.00503	CcSEcCtD
Cefuroxime—Pain—Thalidomide—leprosy	0.00498	0.00498	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Thalidomide—leprosy	0.00477	0.00477	CcSEcCtD
Cefuroxime—Urticaria—Thalidomide—leprosy	0.00463	0.00463	CcSEcCtD
Cefuroxime—Abdominal pain—Thalidomide—leprosy	0.00461	0.00461	CcSEcCtD
Cefuroxime—Body temperature increased—Thalidomide—leprosy	0.00461	0.00461	CcSEcCtD
Cefuroxime—Hypersensitivity—Thalidomide—leprosy	0.00429	0.00429	CcSEcCtD
Cefuroxime—Pruritus—Thalidomide—leprosy	0.00412	0.00412	CcSEcCtD
Cefuroxime—Diarrhoea—Thalidomide—leprosy	0.00399	0.00399	CcSEcCtD
Cefuroxime—Dizziness—Thalidomide—leprosy	0.00385	0.00385	CcSEcCtD
Cefuroxime—Vomiting—Thalidomide—leprosy	0.00371	0.00371	CcSEcCtD
Cefuroxime—Rash—Thalidomide—leprosy	0.00367	0.00367	CcSEcCtD
Cefuroxime—Dermatitis—Thalidomide—leprosy	0.00367	0.00367	CcSEcCtD
Cefuroxime—Headache—Thalidomide—leprosy	0.00365	0.00365	CcSEcCtD
Cefuroxime—Nausea—Thalidomide—leprosy	0.00346	0.00346	CcSEcCtD
